Likang Life Sciences presents AI cancer immunotherapy at Abu Dhabi health summit

Likang Life Sciences, a biotechnology firm focused on AI-enabled personalized cancer immunotherapies, sponsored and exhibited at the Abu Dhabi Future Health Summit 2026, PR Newswire reported.

The summit took place from October 20 to 22 at the ADNEC Centre in Abu Dhabi and was convened by the Department of Health – Abu Dhabi under the theme "To Sense Is to Predict."

Likang used the event to highlight its scientific platform and clinical development programs, marking a significant step in its international outreach efforts.

Likang's Co-Founder and Vice Chairman, Shannon Cheung, was part of a delegation of international health leaders who met with UAE President Sheikh Mohamed bin Zayed Al Nahyan and Abu Dhabi Crown Prince Sheikh Khaled bin Mohamed bin Zayed Al Nahyan during the summit, according to PR Newswire.